AbCellera Biologics Inc. Share Price
NASDAQ: ABCL | Small CapAbCellera Biologics Inc. Stock Performance
Open $6.66 | Prev. Close $6.51 | Circuit Range N/A |
Day Range $6.36 - $6.66 | Year Range $2.75 - $8.41 | Volume 1,56,135 |
Average Traded $6.46 |
AbCellera Biologics Inc. Share Price Today
As of 9 August 2026, AbCellera Biologics Inc.'s share price is $6.58. The stock opened at $6.66, compared to its previous close of $6.51. During today's trading session, AbCellera Biologics Inc.'s share price traded between $6.36 and $6.66, with an average price of $6.51. Over the past 52 weeks, the stock has recorded a high of $8.41 and a low of $2.75. In terms of performance, AbCellera Biologics Inc.'s share price has risen by 82.78% over the last six months and is up 57.79% on a year-on-year basis.
AbCellera Biologics Inc. Share Price Chart
AbCellera Biologics Inc. Stock Fundamentals & Key Indicators
Market Cap $1.97B | PE Ratio (TTM) -13.43 | Dividend Yield N/A |
EPS (TTM) $-0.49 | Revenue (TTM) $75.13M | Return On Equity (TTM) -15.14% |
Profit Margin -194.88% | Debt to Equity 0.07 | Quarterly Earnings Growth YoY -11.76% |
AbCellera Biologics Inc. Quarterly Profit & Loss
All figures in USD
AbCellera Biologics Inc. Annual Profit & Loss
All figures in USD
About AbCellera Biologics Inc.
AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.
AbCellera Biologics Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $5.68 | $6.58 | +15.15% |
Jul 2026 | $7.78 | $5.71 | -27.17% |
Jun 2026 | $6.13 | $7.84 | +26.86% |
May 2026 | $4.13 | $6.18 | +48.74% |
Apr 2026 | $3.53 | $4.16 | +18.88% |
Mar 2026 | $3.48 | $3.50 | -2.92% |
Feb 2026 | $3.56 | $3.60 | -0.55% |
Jan 2026 | $3.46 | $3.62 | +6.16% |
Dec 2025 | $3.58 | $3.41 | -8.82% |
Nov 2025 | $5.54 | $3.74 | -32.49% |
Oct 2025 | $5.08 | $5.54 | +10.25% |
Sep 2025 | $4.13 | $5.03 | +20.50% |